|Bid||2.3100 x 3200|
|Ask||2.3200 x 1000|
|Day's Range||2.2410 - 2.4600|
|52 Week Range||0.9900 - 3.0600|
|Beta (5Y Monthly)||0.85|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 09, 2022 - Mar 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
FOSTER CITY, Calif., September 22, 2022--Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 901,950 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.
Does the September share price for Geron Corporation ( NASDAQ:GERN ) reflect what it's really worth? Today, we will...
FOSTER CITY, Calif., September 08, 2022--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of John F. McDonald as an independent member of its Board of Directors, effective September 7, 2022.